Healthcare ❯ Pharmaceuticals ❯ Clinical Trials ❯ Drug Development

Rare Diseases

Law Firms Press Soleno Investors to Seek Lead Role in Securities Suit by May 5

Plaintiffs say Soleno hid safety risks tied to its only drug.

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR